Main Uses and Therapeutic Intent

Chophytol is a herbal medicinal product derived from the leaf extract of the artichoke (Cynara scolymus). It is primarily utilized to support the digestive system and improve hepatic and renal elimination functions. Its therapeutic application is based on the traditional use of artichoke extract to facilitate the production and flow of bile, which is essential for the breakdown and absorption of dietary fats.

Digestive Support and Dyspepsia

The most common application of Chophytol is the management of functional digestive disorders, often referred to as dyspepsia. It is used to address symptoms associated with slow or difficult digestion, including:

• A sensation of abdominal fullness or bloating.
• Discomfort after meals.
• Excessive intestinal gas (flatulence).
• Mild nausea related to sluggish digestion.

Hepatobiliary Function

Chophytol acts as both a choleretic and a cholagogue. As a choleretic, it stimulates the liver cells to increase the production of bile. As a cholagogue, it promotes the contraction of the gallbladder, aiding the delivery of bile into the small intestine. These actions help to optimize the digestive process and support the liver's role in processing metabolic waste.

Diuretic Properties and Elimination

Beyond its role in digestion, artichoke leaf extract is recognized for its mild diuretic properties. Chophytol is used to assist the kidneys in the elimination of water and metabolic by-products. This support for the body's natural excretory pathways contributes to an overall sense of physiological balance, particularly in individuals prone to minor fluid retention or those seeking to support their body's detoxification processes.

The eligibility for using Chophytol is strictly defined by regulatory documents, which outline the approved population and specific health conditions that prohibit its use.

Eligibility Scope and Restrictions

The medicine is officially labeled "For adults only," meaning its use is not recommended for children and adolescents under 12 years of age due to a lack of established safety data.

Absolute Contraindications prohibit the use of Chophytol in individuals with certain severe conditions. These include bile duct obstruction, severe hepato-cellular insufficiency, and known hypersensitivity to the active substance or any plant of the Asteraceae family (which includes Artichoke).

For Special Populations, use is not recommended during pregnancy or breastfeeding, as safety in these physiological states has not been established. Patients with existing biliary disorders, such as gallstones, should only use this medicine under medical supervision.

Condition-Specific Limitations

• The tablet form is contraindicated in patients with hereditary metabolic disorders like fructose intolerance due to its excipients.
• Individuals using the drinkable solution must be aware of its alcohol content.

Chophytol Interactions with other medicines and products

Official regulatory documentation for Chophytol, a Traditional Herbal Medicinal Product, details interactions based on its formulation, particularly the excipient content of the oral solution.

Official Interaction Profile

Interaction Domain	Official Regulatory Statement
Oral Solution Alcohol Content	Due to the presence of ethanol in the drinkable solution, regulatory texts explicitly instruct users to avoid consumption of any alcoholic beverage.
Drug-Excipient Interaction Risk	Formal warnings are issued against co-administration of the oral solution with Antabuse-inducing medicinal products. These include Disulfiram, certain cephalosporin antibiotics (e.g., Cefoperazone), sulphonylurea hypoglycaemic antidiabetic agents (e.g., Chlorpropamide), and 5-nitroimidazole derivatives (e.g., Metronidazole).
Population-Specific Note	Cautions are specified for Vehicle Drivers and Machine Operators using the oral solution, as the alcohol content may dangerously diminish the ability to drive or operate machinery.
Coated Tablet Formulation	Official documentation for the coated tablet formulation often states that interactions with other medicinal products are Not Applicable.

The interaction structure of Chophytol is primarily defined by the excipient in the oral solution, leading to specific restrictions on alcohol and certain drug combinations. The Artichoke extract (active ingredient) itself has no officially documented pharmacokinetic or pharmacodynamic interactions in regulatory labeling.

Hepatic Enzyme Modulation and Systemic Clearance

Chophytol's primary mode of action involves modulating the activity of key hepatic detoxification enzymes. This interaction facilitates the biotransformation and subsequent elimination of metabolic waste products via the biliary system.

Antioxidant Action on Hepatocytes

Furthermore, Chophytol acts as an antioxidant, chemically reducing reactive oxygen species (ROS) within the cell environment. This action directly influences the structural integrity of hepatocyte cell membranes, helping maintain cellular homeostasis during metabolic processes.

PXR and Biliary Transport Cascade

Its pathway modulation is known to influence canalicular transporter proteins, which mediates an increase in biliary secretion. The mechanistic cascade includes the transcriptional activation of the nuclear receptor PXR (Pregnane X Receptor), a key regulatory step that subsequently influences the downstream transport and flow of bile acids.

Chophytol, an over-the-counter herbal medicine containing an extract of Artichoke leaf (Cynara scolymus), is traditionally used to support digestive and renal elimination functions.

Dosage and Administration

This product is generally intended for adults only and is for oral use.

• Tablet Formulation (200 mg dry extract): The standard dosage is typically 1 to 2 coated tablets taken with water before the three main meals, or when digestive symptoms occur. The duration of treatment is usually advised to be limited to 2 to 3 weeks.

• Oral Solution Formulation (20% soft aqueous extract): For the liquid form, the standard dosage is typically 1 teaspoon (5 ml) taken with water before each of the three main meals, or at the time symptoms present. Due to the presence of alcohol in the solution, caution is advised, and consumption of alcoholic beverages should be avoided during treatment.

Formulation	Dosage (Adults Only)	Timing	Max Duration (Typically)
Coated Tablet (200 mg)	1–2 tablets	Before 3 main meals or when symptoms occur	2–3 weeks
Oral Solution (20%)	1 teaspoon (5 ml)	Before 3 main meals or when symptoms occur	Not specified

Important Considerations

Do not exceed the stated recommended daily dose. Treatment should be stopped and a healthcare professional consulted in cases of diarrhea or abdominal pain. This medication is contraindicated in cases of bile duct obstruction or severe hepatocellular insufficiency. Due to insufficient data, use is generally not recommended during pregnancy or lactation. Consult a doctor or pharmacist if you are taking other medications to check for potential interactions.

Research Evidence / Overview of Studies for Chophytol

The research evidence for the active ingredient in Chophytol, artichoke leaf extract (Cynara scolymus), is used traditionally in research exploring how symptoms change over time. The scientific understanding documented in regulatory and scientific sources is built upon a combination of randomized controlled trials (RCTs) and acute physiological studies. This overview summarizes the research landscape according to authoritative governmental and peer-reviewed sources.

---

Evidence for Use in Functional Dyspepsia and Digestive Symptoms

This section summarizes the types of clinical studies, primarily short-term Randomized Controlled Trials (RCTs), that have explored the relationship between the active ingredient and patient-reported outcomes like bloating, fullness, and post-meal heaviness in adult populations. It details the specific symptoms and symptom scores that researchers chose to measure in these trials.

The evidence landscape includes studies that are relevant in trials assessing short-term or episodic symptom patterns. Research examined how symptoms evolved in study populations of adults diagnosed with functional dyspepsia or those reporting common digestive discomfort. Researchers monitored patient-reported outcomes describing perceived discomfort, focusing on the change in severity and frequency of symptoms such as bloating, fullness, and feelings of post-meal heaviness. Findings were mixed across some trials, and the research often relied on subjective patient reporting of their experiences.

---

Evidence for Supporting Bile Secretion and Flow

This area will summarize the evidence base for the traditional claim of the active ingredient as a choleretic/cholagogue agent, detailing the acute physiological and mechanistic studies (such as human trials measuring bile volume) that have described this biological activity. The focus will be on the laboratory and acute measures used in these studies.

Acute studies examined research scenarios related to the traditional claim of influencing bile flow, which is relevant in evidence describing how symptoms are measured in relation to digestive processes. These acute studies monitored physiological markers, specifically by measuring the volume of bile secretion over a short period of minutes or hours following administration. These acute studies reported measurements that reflecting shifts in the volume of bile secreted. The correlation between the acute measurements and sustained symptomatic relief remains uncertain.

---

Research on Long-Term Effects and Follow-Up Duration

This section will outline what the authoritative sources and published literature indicate about the duration of studies conducted, summarizing the typical short-term (4-8 week) focus of the evidence and what is currently known and unknown about sustained effects over longer periods.

Follow-up durations were limited, typically lasting only 4 to 8 weeks in the trials that examined digestive symptoms. This means there is limited information for long-term outcomes, and the long-term changes over months or years are not fully established. Research provides context on short-term changes but does not determine whether an individual will respond similarly after prolonged use.

---

What is Still Uncertain About the Research

The available evidence contributes to the broader evidence landscape, but several limitations remain. Sample sizes were modest in some key studies, and evidence quality varies across studies due to differences in extract preparation and methodology. Furthermore, the findings reflect group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly. While the research describes short-term changes in symptoms that were observed in the studied populations, data are still emerging, and certainty remains low in areas such as long-term characterization and the effects in special populations.

Common questions about Chophytol (FAQ)

Q: What is Chophytol?

Chophytol is a pharmaceutical preparation derived from the artichoke leaf extract (Cynara scolymus). It is studied for its potential properties in supporting the function of the liver and biliary system.

---

Q: What is Chophytol used for?

It is traditionally used to address minor digestive discomforts that may be related to impaired bile flow. Research has explored its application in supporting overall digestive health and hepatic function.

---

Q: Does Chophytol cure liver conditions?

No, Chophytol is not indicated to cure or treat severe liver diseases or conditions. The available evidence focuses on its potential role in managing functional digestive symptoms and supporting normal bile flow, not on definitive therapeutic cure of serious conditions.

---

Q: How quickly does Chophytol work?

The onset of effect for any digestive support product, including Chophytol, is highly variable among individuals. Any reported changes may depend on the duration and consistency of use. Specific timelines should be discussed with a healthcare provider.

---

Q: Is Chophytol safe to take with other medications?

As with any medicinal preparation, the potential for interaction exists. It is essential to consult a healthcare professional or pharmacist before starting Chophytol if you are currently taking other medications, especially those for chronic conditions or other digestive aids.

---

Q: Where can I find the official prescribing information for Chophytol?

Official and complete prescribing information, including approved indications, contraindications, and potential side effects, is provided within the package insert and through official regulatory documents in your region.

How to Store and Dispose of Chophytol?

Chophytol requires no special precautions for storage, according to official regulatory documentation. The product is not required to be stored under specific temperature or light protection conditions.

Attribute	Coated Tablets	Oral Solution
Special Storage	Not required	Not required
Shelf Life	3 years	4 years

No special requirements are indicated for the handling or disposal of the unused medicinal product or waste materials derived from it. Regulatory labeling states the product does not require specific environmental or controlled-waste disposal procedures. The only official time constraint is the stated shelf life, which dictates the product’s maximum duration of stability.